Skip to main content

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

  • PhasePhase 2
  • StatusRecruiting
  • Planned enrollment45 people
  • Recruiting US sites3
  • SponsorAlice Chung
  • RegistryNCT06092892

Recruitment re-checked on ClinicalTrials.gov Oct 30, 2026. Public record; not medical advice.

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases: a one-minute explainerNCT060928921 min

Eligibility

Who can join

The film gives the main points. The full list below is copied from the registry; the study team makes the final decision.

  • Age45 Years to no maximum
  • SexFemale
  • Healthy volunteersNo

You may be able to join if

  • Women age ≥ 45
  • Clinical T1-2N0 ER+ invasive breast cancer
  • US detected biopsy proven axillary nodal disease
  • Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.

You cannot join if

  • Palpable nodes on physical exam
  • Her2+ or ER- invasive breast cancer
  • Extranodal extension > 3 mm on nodal biopsy
  • More than 2 suspicious nodes on preoperative imaging

The treatment

How it is intended to work

This is how the treatment is meant to work. Whether it helps, and how safe it is, is what this trial is testing.

Treatments listed in the registry

  • Breast Surgery (BCS or mastectomy) with TAD/SNB (Procedure): Breast surgery (BCS or mastectomy) with TAD/SNB & Adjuvant Radiation therapy
  • Adjuvant Radiation Therapy (Radiation): Breast surgery (BCS or mastectomy) with TAD/SNB & Adjuvant Radiation therapy

The study

Treatment groups

Na · Single Group · masking: None

Single Arm (Experimental)

What it involves

Procedures

As the registry describes them. Requirements to join, such as a tissue sample, are in the eligibility list above even when on-study procedures are optional. Ask the study team which steps apply to you.

  • surgery: Part of the study plan
  • radiation: Part of the study plan

Goals

What the study measures

Main goals

  • Regional recurrence rate (5 Years)

Other goals

  • Local recurrence rate
  • Disease-free survival (DFS)
  • Breast cancer specific survival (BCSS) rate
  • Overall survival (OS)

Planned enrollment: 45 (estimated).

Where

Recruiting US sites

  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California
  • CS Cancer at Huntington Cancer Center, Pasadena, California
  • CS Cancer at Valley Oncology Medical Group, Tarzana, California

Site status as of Oct 30, 2026. Check the live record before contacting a site.

Sources

Where this comes from

Registry record reviewed as fetched Oct 30, 2026, last updated by the sponsor Aug 9, 2026. Public record; not medical advice.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.